Jacqueline Claire Lupo
Chief Executive Officer at LOPHOS HOLDINGS INC.
Net worth: 660 000 $ as of 2024-04-29
Profile
Jacqueline Claire Lupo is the founder of Lophos Pharmaceuticals Corp., where she holds the title of President, CEO & Director since 2021.
She is also the founder of Canalytica Corp.
Ms. Lupo's current job is as the Chief Executive Officer & Director at Lophos Holdings, Inc. since 2021.
Additionally, she is currently working as a Manager at Northern Green Canada, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LOPHOS HOLDINGS, INC.
14.90% | 2024-02-11 | 11,000,000 ( 14.90% ) | 660 000 $ | 2024-04-29 |
Jacqueline Claire Lupo active positions
| Companies | Position | Start |
|---|---|---|
| LOPHOS HOLDINGS INC. | Chief Executive Officer | 2021-12-22 |
Lophos Pharmaceuticals Corp.
 Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Founder | 2020-12-31 |
| Northern Green Canada, Inc. | Corporate Officer/Principal | - |
Former positions of Jacqueline Claire Lupo
| Companies | Position | End |
|---|---|---|
| Canalytica Corp. | Founder | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| LOPHOS HOLDINGS INC. | Process Industries |
| Private companies | 3 |
|---|---|
Lophos Pharmaceuticals Corp.
Lophos Pharmaceuticals Corp. BiotechnologyHealth Technology Part of Lophos Holdings, Inc., Lophos Pharmaceuticals Corp. is a Canadian biosciences company that specializes in peyote cultivation, research, and sale. The company is also licensed to possess, sell/provide, send, transport and deliver controlled substances covered by their controlled substances dealers license (CSDL), namely mescaline, psilocin, psilocybin, LSD, DMT, and ketamine, as well as produce mescaline, psilocin, and psilocybin. Lophos Pharmaceuticals was acquired by Greenridez 2.0 Acquisitions Corp. on January 21, 2022. | Health Technology |
| Northern Green Canada, Inc. | Consumer Non-Durables |
| Canalytica Corp. |
- Stock Market
- Insiders
- Jacqueline Claire Lupo
